To this end, we inoculated mice with WT:WT or WT:IFNγR2-mutant tumor cells and administered 50 μg of recombinant mouse IFN-γ i.p. on days 7, 10, 13, and 16 and analyzed tumor cell composition on day 18 after tumor cell inoculation. Here, IFNG is linked to neoplasm.